美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Virtus LifeSci Biotech Clinical Trials ETF

49.94

+0.55521.12%

盤後：49.75-0.1900-0.38%19:30 EDT

成交量：1.04萬

成交額：52.12萬

市值：4,744.30萬

市盈率：- -

高：50.40

開：49.43

低：49.43

收：49.38

52周最高：56.18

52周最低：23.81

股本：95.00萬

流通股本：95.00萬

量比：0.66

換手率：1.10%

股息：0.66

股息率：1.32%

淨資產收益率：--

總資產收益率：--

市淨率：1.07

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

凱萊英旗下公司入選上海市生物醫藥研發和檢測用物品進口試點企業目錄

上海市商務委等六部門和單位關於公布上海市生物醫藥研發和檢測用物品進口試點企業目錄的通知

中國生物製藥：LM-364獲NMPA及FDA臨床試驗批准

南方财经网

已致469死977失聯！尼方技術團隊確認災難原因：尼泊爾境內冰川崩塌致山體滑落阻塞河流，決堤後洪水傾瀉而下

每日经济新闻

據BBC，哈里王子、妻子梅根及其子女今日將返回英國。

積雪融水致河水暴漲，中尼邊境山洪引發泥石流

全球平均海温創歷史新高，「或是上一個間冰期以來最暖海温」

舒泰神：子公司STSP-0601獲美國FDA臨床試驗許可

駿利亨德森投資：專利到期倒逼藥企擴張生物科技併購、IPO市場同步復甦

智通财经网

美銀證券：中國CXO行業受惠生物科技融資強勁上調藥明康德等目標價

悦康藥業(688658.SH)子公司YKYY033注射液獲得FDA臨床試驗批准

悦康藥業：子公司YKYY033注射液獲美國FDA臨床試驗批准

聯邦制藥：UBT48128片獲美國FDA臨床試驗批准

聯邦制藥(03933)：UBT48128片獲美國FDA臨床試驗批准

石藥集團：猴痘mRNA疫苗獲美國FDA臨床試驗批准

從「福利槍」利益鏈到深層槍支崇拜，泰國為何反覆上演槍擊悲劇？

市場消息：特朗普獲准在這起 100 億美元的 BBC 誹謗訴訟中暫緩提交財務細節。

特朗普當ABC記者面説喜歡BBC

特朗普在空軍一號上回答美媒提問時，得知記者來自ABC，稱「那更糟，還不如BBC呢」！

「微兔早班車」別錯過這些精彩新聞

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BBC/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":49.94,"timestamp":1789416000000,"preClose":49.3848,"halted":0,"volume":10446,"hourTrading":{"tag":"盘后","latestPrice":49.75,"preClose":49.94,"latestTime":"19:30 EDT","volume":998,"amount":48990.84,"timestamp":1789428601873,"change":-0.19,"changeRate":-0.003805,"amplitude":0.03364},"delay":0,"changeRate":0.011242325573860769,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"未開盤","change":0.5552,"latestTime":"09-14 16:00:00 EDT","open":49.43,"high":50.4,"low":49.43,"amount":521165.83599600004,"amplitude":0.019642,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":49.3848,"sharesOutstanding":900004,"nav":49.423,"aum":46951614.8,"dividendRate":0.0131,"bidAskSpread":0.002083,"preHourTrading":{"tag":"盘前","latestPrice":49.028,"preClose":49.3848,"latestTime":"09:03 EDT","volume":15,"amount":735.42,"timestamp":1789391005671,"change":-0.3568,"changeRate":-0.007225,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":49.75,"preClose":49.94,"latestTime":"19:30 EDT","volume":998,"amount":48990.84,"timestamp":1789428601873,"change":-0.19,"changeRate":-0.003805,"amplitude":0.03364},"volumeRatio":0.656436,"impliedVol":0.3174,"impliedVolPercentile":0.392},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.656436,"shares":950000,"dividePrice":0.6568,"high":50.4,"amplitude":0.019642,"preClose":49.3848,"low":49.43,"week52Low":23.81,"pbRate":"1.07","week52High":56.18,"institutionHeld":0,"latestPrice":49.94,"eps":0,"divideRate":0.013152,"volume":10446,"delay":0,"ttmEps":0,"open":49.43,"prevYearClose":38.56,"prevWeekClose":49.3848,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":53.71,"twentyDayClose":52.8675,"sixtyDayClose":44.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664383627","title":"凱萊英旗下公司入選上海市生物醫藥研發和檢測用物品進口試點企業目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383627?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:03","pubTimestamp":1788246222,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBIX","IBBQ","BBC","RND","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836502","title":"上海 市商務委等六部門和單位關於公布上海市生物醫藥研發和檢測用物品進口試點企業目錄的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836502?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 14:44","pubTimestamp":1788245063,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBIX","WRND","IBBQ","BBC","RND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068895","title":"中國生物製藥：LM-364獲NMPA及FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068895","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068895?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 16:36","pubTimestamp":1787906160,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电，中国生物制药（01177.HK）发布自愿公告，公司全资附属公司礼新医药科技（上海）有限公司自主研发的国家1类创新药LM-364“NECTIN-4TMEADC”已获得中国国家药品监督管理局（NMPA）临床试验默示许可，拟用于晚期实体瘤治疗；此前于2026年4月已获美国食品药品监督管理局（FDA）临床试验许可，并在澳大利亚正式启动临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858178370.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858178370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","BK1191","IE00BZ08YT58.USD","BBC","HK0000165453.HKD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662051832","title":"已致469死977失聯！尼方技術團隊確認災難原因：尼泊爾境內冰川崩塌致山體滑落阻塞河流，決堤後洪水傾瀉而下","url":"https://stock-news.laohu8.com/highlight/detail?id=2662051832","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662051832?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 13:53","pubTimestamp":1787896380,"startTime":"0","endTime":"0","summary":"尼泊尔旅游委员会发言人表示，仍有178名印度游客失联。26日，尼泊尔北部热索瓦地区暴发山洪。尼泊尔努瓦果德地区是此次泥石流的重灾区之一，泥石流灾害导致当地道路被淤泥堵塞，给救援工作带来很大压力。尼泊尔国家减灾管理局官员表示，他们的技术团队已确认，崩塌发生在位于尼泊尔境内、毗邻尼泊尔和中国边界伦德河的蓝塘里壤峰。堤坝决堤后，洪水倾泻而下，造成毁灭性灾害。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-28/doc-inipwait8920270.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-28/doc-inipwait8920270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715370","title":"據BBC，哈里王子、妻子梅根及其子女今日將返回英國。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715370","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 19:27","pubTimestamp":1787743654,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662859792","title":"積雪融水致河水暴漲，中尼邊境山洪引發泥石流","url":"https://stock-news.laohu8.com/highlight/detail?id=2662859792","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662859792?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:39","pubTimestamp":1787737140,"startTime":"0","endTime":"0","summary":"当地官员认为，积雪融化导致河水暴涨，进而引发了此次洪灾。尼泊尔总理巴伦德拉·沙阿已召开紧急会议全面评估灾情。当局表示，拉苏瓦县两个哨所共有13名武警人员失踪，且已无法与数十名其他警员取得联系。与此同时，位于中方一侧的吉隆口岸附近发生泥石流灾害，当地反映可能有人员失联。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-26/doc-iniprumt6089672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662887427","title":"全球平均海温創歷史新高，「或是上一個間冰期以來最暖海温」","url":"https://stock-news.laohu8.com/highlight/detail?id=2662887427","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662887427?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 11:16","pubTimestamp":1787627760,"startTime":"0","endTime":"0","summary":"据多家外媒24日报道，欧盟哥白尼气候变化服务中心披露数据显示，全球非极地海域平均海面温度于8月22日达到21.1℃，刷新有记录以来的最高值。渥太华大学教授瑞安·卡茨-罗森在X上写道： “这甚至可能是12.5万年前的上一个间冰期以来最温暖的海面温度。”专家认为，在这一反常时段出现历史新高，凸显出全球海洋持续升温的严峻趋势。BBC报道称，英国及欧洲周边海域也持续出现异常高温。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-25/doc-inipnyqs9667453.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-25/doc-inipnyqs9667453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402884","title":"舒泰神：子公司STSP-0601獲美國FDA臨床試驗許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402884?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 16:22","pubTimestamp":1787214150,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","IWO","JDOC","MRNY","BIS","IBB","SPCK","FBT","MRNX","IJT","BK4588","BIB","PBE","BK4582","GTPE","BBP","IBBJ","IYG","BBC","QSML","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659138517","title":"美銀證券：中國CXO行業受惠生物科技融資強勁 上調藥明康德等目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138517","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138517?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 12:41","pubTimestamp":1786596060,"startTime":"0","endTime":"0","summary":"模拟交易客户端美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-08-13/doc-inincxku3329313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","IBRN","APXH","02359","603259","BMED","CXO","BBC","SURI","WX","MEDI","XBIX","IDNA","LFSC","PSIL","PSCH","SMCO","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927439","title":"悦康藥業(688658.SH)子公司YKYY033注射液獲得FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927439","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927439?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:16","pubTimestamp":1786522575,"startTime":"0","endTime":"0","summary":"智通财经APP讯，悦康药业(688658.SH)发布公告，公司子公司北京悦康科创医药科技股份有限公司于近日获得美国食品药品监督管理局(简称“FDA”)关于同意YKYY033注射液用于预防和治疗动静脉血栓临床试验申请的函告。据悉，该产品已于2026年6月和7月获得国家药品监督管理局(NMPA)多项抗凝相关适应症的临床试验批准，临床Ⅰ期研究正在稳步推进中。本次顺利获得美国FDA临床试验许可，标志着产品正式取得海外临床开发资格。依托已获批的全场景血栓防治适应症矩阵，公司将开展多适应症差异化临床探索，精准对标全球主流抗凝治疗指南与临床标准，助力填补全球及国内高安全性、长效核酸类抗凝药物的市场空白。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688658","BBC","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927616","title":"悦康藥業：子公司YKYY033注射液獲美國FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927616?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:06","pubTimestamp":1786522018,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999711","title":"聯邦制藥：UBT48128片獲美國FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999711?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 18:08","pubTimestamp":1786442936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990999","title":"聯邦制藥(03933)：UBT48128片獲美國FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990999","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990999?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 18:08","pubTimestamp":1786442924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，本公司全资附属公司联邦生物科技有限公司自主研发的1类创新药UBT48128片关于超重或肥胖适应症及2型糖尿病适应症的新药临床试验注册申请获美国食品药品监督管理局批准，IND编号分别为182060和182061。多种动物模型的临床前研究表明，UBT48128可显著降低体重和血糖，且减重效果优于目前已上市的同类产品。预期本产品将于超重或肥胖及2型糖尿病展现出良好的治疗获益前景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BBC","03933","IE00B3M56506.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658207980","title":"石藥集團：猴痘mRNA疫苗獲美國FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658207980","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658207980?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657624764","title":"從「福利槍」利益鏈到深層槍支崇拜，泰國為何反覆上演槍擊悲劇？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657624764","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657624764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 07:20","pubTimestamp":1786144800,"startTime":"0","endTime":"0","summary":"当地时间8月7日上午，泰国暖武里府一所中学发生枪击事件，成为该国今年发生的第二起校园枪击案，折射出该国的枪支管制问题以及深层次的拥枪文化。当地时间2026年8月7日，泰国暖武里府挽坤艾区，校园枪击案受害者的遗体被抬出学校场地。对于外国公民而言，泰国法律则明确禁止其拥有枪支。近年来，泰国政府持续收紧枪支管理措施。根据总理阿努廷的指示，泰国政府要求全面加强枪支监管。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-08/doc-inimqccz6652387.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-08/doc-inimqccz6652387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465660","title":"市場消息：特朗普獲准在這起 100 億美元的 BBC 誹謗訴訟中暫緩提交財務細節。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465660?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 00:38","pubTimestamp":1786034321,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656323161","title":"特朗普當ABC記者面説喜歡BBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2656323161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656323161?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 14:29","pubTimestamp":1785738567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656406363","title":"特朗普在空軍一號上回答美媒提問時，得知記者來自ABC，稱「那更糟，還不如BBC呢」！","url":"https://stock-news.laohu8.com/highlight/detail?id=2656406363","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656406363?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 12:44","pubTimestamp":1785732240,"startTime":"0","endTime":"0","summary":"国是直通车当地时间8月2日，美国总统特朗普在空军一号回答美国广播公司（ABC）记者提问时，反复确认对方来自哪家媒体，并称“ABC太糟糕，我更喜欢BBC”。此前，特朗普曾对BBC发起一项100亿美元的诉讼，但在7月中旬他撤销了这项诉讼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-03/doc-inikzkki4586296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656345037","title":"「微兔早班車」別錯過這些精彩新聞","url":"https://stock-news.laohu8.com/highlight/detail?id=2656345037","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656345037?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 06:52","pubTimestamp":1785711120,"startTime":"0","endTime":"0","summary":"驻日美军多名士兵涉嫌酒驾和猥亵被捕日本冲绳县近日发生多起驻日美军士兵被捕案件，其中两人涉嫌酒驾，一人涉嫌公然猥亵。事发时，这名士兵处于醉酒状态。经医疗机构全力救治，截至 8 月 2 日 16 时，4 名伤员因伤势过重不幸离世，2 名伤者仍在积极救治中。事故原因调查和相关善后工作正在开展中。机上乘客包括两名德国游客、两名西班牙游客和七名意大利游客。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-03/doc-inikytnt6314751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}